Profile
Sector:
HealthcareIndustry:
Medical Instruments & SuppliesCountry:
United StatesIPO:
01 March 1990Website:
http://www.hologic.comNext earnings report:
31 January 2025Last dividends:
N/ANext dividends:
N/APrice
regular market | 7 min agoDividend
Analysts recommendations
Institutional Ownership
HOLX Latest News
Hologic (HOLX) has received quite a bit of attention from Zacks.com users lately. Therefore, it is wise to be aware of the facts that can impact the stock's prospects.
Hologic (HOLX) has been getting a lot of interest from users on Zacks.com recently. As a result, it's important to understand the factors that could affect the stock's future.
Even though Hologic recently reported lower earnings than expected, its strong product range and smart investment strategy may still attract investors.
HOLX's results for the fourth quarter of fiscal 2024 highlight the strong and lasting growth of its operations.
Hologic, Inc. (NASDAQ:HOLX) will hold its Q4 2024 Earnings Conference Call on November 4, 2024, at 4:30 PM ET. The call will feature key company leaders, including Ryan Simon, Stephen MacMillan, Essex Mitchell, and Karleen Oberton. Various analysts from different firms will also participate in the discussion.
The financial results for Hologic (HOLX) provide an overview of the company's performance for the quarter that ended in September 2024. It may be helpful to compare some important metrics with Wall Street predictions and figures from the same period last year.
Hologic (HOLX) reported quarterly earnings of $1.01 per share, which is slightly below the Zacks Consensus Estimate of $1.02 per share. This is an increase compared to earnings of $0.89 per share from the same period last year.
In the most recent trading session, Hologic (HOLX) finished at $80.46, which is a decrease of 0.46% compared to the day before.
Hologic (HOLX) has the right mix of two important factors that could lead to a strong earnings report soon. Get ready for the main expectations.
HOLX's fourth-quarter results for fiscal 2024 are anticipated to show strong performance in the Diagnostics sector, primarily driven by the core Molecular franchise.
What type of business is Hologic?
Hologic, Inc. develops, manufactures, and supplies diagnostic products, medical imaging systems, and surgical products for women's health through early detection and treatment. The company conducts molecular diagnostic tests Aptima to detect infectious microorganisms; quantitative viral load tests Aptima for HIV, hepatitis C, and hepatitis B; Aptima SARS-CoV-2 and Panther Fusion SARS-CoV-2 tests for detecting SARS-CoV-2; ThinPrep system for cytology use; a rapid fetal fibronectin test to help doctors assess the risk of premature birth; diagnostic tests for detecting group B streptococcus. The company also offers breast imaging and analysis services. Hologic, Inc. was founded in 1985 and is headquartered in Marlborough, Massachusetts.
What sector is Hologic in?
Hologic is in the Healthcare sector
What industry is Hologic in?
Hologic is in the Medical Instruments & Supplies industry
What country is Hologic from?
Hologic is headquartered in United States
When did Hologic go public?
Hologic initial public offering (IPO) was on 01 March 1990
What is Hologic website?
https://www.hologic.com
Is Hologic in the S&P 500?
Yes, Hologic is included in the S&P 500 index
Is Hologic in the NASDAQ 100?
No, Hologic is not included in the NASDAQ 100 index
Is Hologic in the Dow Jones?
No, Hologic is not included in the Dow Jones index
When was Hologic the previous earnings report?
No data
When does Hologic earnings report?
The next expected earnings date for Hologic is 31 January 2025